CNS Disease in ALK-Positive NSCLC: Monitoring and Systemic vs. Radiation Therapy

Apr 12, 2016 · 2m 29s
CNS Disease in ALK-Positive NSCLC: Monitoring and Systemic vs. Radiation Therapy
Description
Dr. Ross Camidge, University of Colorado, discusses management of CNS progression for ALK-positive NSCLC including monitoring frequency and preferences between systemic and radiation therapy.
Information
Author cancerGRACE
Organization cancerGRACE
Website -
Tags

Looks like you don't have any active episode

Browse Spreaker Catalogue to discover great new content

Current

Podcast Cover

Looks like you don't have any episodes in your queue

Browse Spreaker Catalogue to discover great new content

Next Up

Episode Cover Episode Cover

It's so quiet here...

Time to discover new episodes!

Discover
Your Library
Search